Social Media Follow-up Nursing for Atopic Dermatitis
Impact of Social Media-Based Networked Follow-up Nursing Intervention on Itch Severity and Self-care Ability in Patients With Atopic Dermatitis
1 other identifier
interventional
100
1 country
1
Brief Summary
This is a randomized controlled study to evaluate the effectiveness of a social media-based (WeChat) networked nursing follow-up intervention compared to conventional nursing care for patients with atopic dermatitis. The study aims to determine the impact of the intervention on itch severity, skin condition, and self-care ability over a 6-month period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedFirst Submitted
Initial submission to the registry
August 20, 2025
CompletedFirst Posted
Study publicly available on registry
August 27, 2025
CompletedAugust 27, 2025
August 1, 2025
2 years
August 20, 2025
August 20, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Change in Itch Severity
Measured by the Numeric Rating Scale (NRS) for itching. The scale ranges from 0 (no itching) to 10 (very severe itching), where patients rate the most severe itching experienced in the past 24 hours. A higher score indicates more severe itching.
Baseline, 6 Months
Change in Self-care Ability
Measured by the Exercise of Self-Care Agency Scale (ESCA). The scale includes 43 items across four dimensions (self-care skills, self-responsibility, self-concept, and health knowledge). It uses a Likert 5-point scoring system (0 to 4 points). A higher total score indicates stronger self-care ability.
Baseline, 6 Months
Secondary Outcomes (2)
Change in Eczema Area and Severity Index (EASI)
Baseline, 6 Months
Change in Overall Evaluation Score
Baseline, 6 Months
Study Arms (2)
Experimental: Social Media-Based Nursing Intervention Group
EXPERIMENTALPatients (n=50) received networked follow-up nursing intervention via a popular social media platform (WeChat). This included weekly educational materials, daily Q\&A sessions, personalized care plans, remote monitoring of skin condition via photos, continuous health education, and a peer communication group. This intervention was provided as an adjunct to standard medical care.
Active Comparator: Conventional Nursing Care Group
ACTIVE COMPARATORPatients (n=50) received conventional nursing care. This included verbal health education at discharge, distribution of educational materials and a follow-up handbook, and weekly follow-up phone calls from a liaison nurse to assess adherence and provide guidance. This intervention was provided as an adjunct to standard medical care.
Interventions
A structured nursing follow-up program delivered through a WeChat group. The program included regular sharing of educational content (articles, videos), personalized care advice, remote photo-based monitoring by medical staff, and peer support within the group. The intervention was managed by a dedicated team of dermatologists and nurses.
A standard care follow-up protocol involving verbal education at discharge, provision of printed health materials, and proactive weekly telephone calls to monitor the patient's condition, correct improper self-care actions, and encourage clinic visits if necessary.
Eligibility Criteria
You may qualify if:
- Aged 20-60 years;
- Diagnosed according to the Williams diagnostic criteria for atopic dermatitis;
- Signed informed consent.
You may not qualify if:
- Severe, progressive, and uncontrolled major organ or systemic diseases (including cardiovascular, liver, lung, and kidney diseases), other autoimmune diseases, or malignant tumors;
- Pregnant or lactating women;
- Presence of other skin diseases;
- Mental health disorders;
- Previous experience with similar follow-up nursing interventions;
- Severe complications such as infections or allergies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
the Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
August 20, 2025
First Posted
August 27, 2025
Study Start
May 1, 2022
Primary Completion
May 1, 2024
Study Completion
May 1, 2024
Last Updated
August 27, 2025
Record last verified: 2025-08